Anto Francis, Agongo Ibrahim Haruna, Asoala Victor, Awini Elizabeth, Oduro Abraham Rexford
School of Public Health, University of Ghana, Legon, P.O. Box LG 13, Accra, Ghana.
Navrongo War Memorial Hospital, Navrongo, P.O. Box 34, UE/R, Ghana.
J Trop Med. 2019 Jun 2;2019:6712685. doi: 10.1155/2019/6712685. eCollection 2019.
Intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) decreases placental parasitaemia and improves birth outcomes. Currently, WHO recommends three or more doses of SP given during antenatal care (ANC), spaced one month apart after 16 weeks of gestation till delivery. This study determined the level of uptake of SP and its association with birth outcomes in rural northern Ghana.
A survey was carried out at the War Memorial Hospital in Navrongo, Ghana, among mothers who had delivered within ten weeks and were seeking postnatal care. Data on time of first ANC, number of visits, receipt of IPTp-SP, and birth outcomes were extracted from the antenatal records of 254 mothers. Mothers were interviewed on their background characteristics and obstetric history. Chi-square tests and logistic regression were carried out to determine association between antenatal indicators, uptake of IPTp-SP, and birth outcomes using Stata version 13.
Uptake of three-five doses of SP was IPT3 =76.4%, IPT4 =37.3%, and IPT5 = 16.0%. Receipt of first dose of SP at 16, 17-24, and 25-36 weeks of gestation was 16.9%, 56.7%, and 26.4%, respectively. Taking the first dose of SP during the second trimester allowed for taking ≥3 doses of SP compared to taking the first dose during the third trimester (2 = 60.1, <0.001). Women who made ≥4 visits were more likely to receive ≥3 doses of SP compared to those who made <4 visits (2 = 87.6, <0.001). Women who received ≥ 3 doses of SP were more likely (OR = 3.3; 95% CI: 1.69-6.33) to give birth at term and also have normal weight babies (OR =4.0; 95% CI: 1.98-8.06).
Uptake of three or more doses of SP contributed to improved pregnancy outcomes. Increased efforts towards improving early ANC attendance could increase uptake of SP and improve pregnancy outcomes.
孕期使用周效磺胺-乙胺嘧啶(IPTp-SP)进行疟疾间歇性预防治疗可降低胎盘寄生虫血症并改善分娩结局。目前,世界卫生组织建议在产前保健(ANC)期间给予三剂或更多剂的周效磺胺-乙胺嘧啶,在妊娠16周后每隔一个月给药一次直至分娩。本研究确定了加纳北部农村地区周效磺胺-乙胺嘧啶的使用水平及其与分娩结局的关联。
在加纳纳瓦龙戈的战争纪念医院对分娩后十周内寻求产后护理的母亲进行了一项调查。从254名母亲的产前记录中提取了首次产前保健时间、就诊次数、IPTp-SP的接受情况和分娩结局的数据。就母亲的背景特征和产科病史进行了访谈。使用Stata 13版进行卡方检验和逻辑回归,以确定产前指标、IPTp-SP的使用情况和分娩结局之间的关联。
接受三至五剂周效磺胺-乙胺嘧啶的比例分别为:IPT3 = 76.4%,IPT4 = 37.3%,IPT5 = 16.0%。在妊娠16周、17 - 24周和25 - 36周接受首剂周效磺胺-乙胺嘧啶的比例分别为16.9%、56.7%和26.4%。与在孕晚期服用首剂相比,在孕中期服用首剂周效磺胺-乙胺嘧啶更有可能服用≥3剂(χ² = 60.1,P < 0.001)。与就诊次数<4次的女性相比,就诊次数≥4次的女性更有可能接受≥3剂周效磺胺-乙胺嘧啶(χ² = 87.6,P < 0.001)。接受≥3剂周效磺胺-乙胺嘧啶的女性足月分娩的可能性更大(OR = 3.3;95%置信区间:1.69 - 6.33),并且生出体重正常婴儿的可能性也更大(OR = 4.0;95%置信区间:1.98 - 8.06)。
接受三剂或更多剂周效磺胺-乙胺嘧啶有助于改善妊娠结局。加大力度提高早期产前保健就诊率可增加周效磺胺-乙胺嘧啶的使用并改善妊娠结局。